COVID-19 and the enteric system: rapidly propagating issues.


Journal

Minerva medica
ISSN: 1827-1669
Titre abrégé: Minerva Med
Pays: Italy
ID NLM: 0400732

Informations de publication

Date de publication:
Apr 2023
Historique:
medline: 3 5 2023
pubmed: 23 3 2022
entrez: 22 3 2022
Statut: ppublish

Résumé

The newly described SARS-CoV-2 respiratory virus is now righteously presenting as an ominous threat, based on the speed with which it originated a zoonosis from bats; advancing at a similar rate, the virus has placed mankind before a pandemic, with an infection toll of some 431 million, and a lethality of 5,9 million (as of February 25, 2022). The size of the harm that this agent can unleash against us is appallingly wide, from brain ischemia to foot chilblain, passing by heart massive infarction. Designing a possible response, we reappraised the well-known equation depression-inflammation, and tested the hypothesis that an upgraded ease-of-mind might help reduce the host's hospitality towards SARS-CoV-2. With time passing, it becomes increasingly evident that the virus shall tend to progressively occupy spaces, replacing pandemics with an apparently calm endemicity. This will have to be avoided, and surveillance of society on psychological terms will be one tenet. Needless to say, the role of the enteric tract in these issues is growing higher, and it will be narrated to seal the matters with the last (not the least) touch of glue.

Identifiants

pubmed: 35315634
pii: S0026-4806.22.08077-6
doi: 10.23736/S0026-4806.22.08077-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

217-223

Auteurs

Giovanni C Actis (GC)

The Medical Center Practice Office, Turin, Italy.

Rinaldo Pellicano (R)

Unit of Gastroenterology, Molinette Hospital, Città della Salute e della Scienza, Turin, Italy.

Sharmila Fagoonee (S)

Institute of Biostructure and Bioimaging, National Research Council, Molecular Biotechnology Center, Turin, Italy.

Davide G Ribaldone (DG)

Division of Gastroenterology, Department of Medical Sciences, University of Turin, Turin, Italy - davidegiuseppe.ribaldone@unito.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH